Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:47 AM
Ignite Modification Date:
2025-12-25 @ 4:47 AM
NCT ID:
NCT02452918
Eligibility Criteria:
Inclusion Criteria:
* Diagnosis of ABSSSI (wound infection, cellulitis/erysipelas, or cutaneous abscess) suspected or confirmed to be caused by a Gram-positive pathogen requiring IV therapy
* Must be currently being treated with chronic warfarin therapy\* \*Participants in the non-warfarin group are not required to be on chronic warfarin therapy.
Exclusion Criteria:
* Known or suspected bacteremia, sepsis or refractory shock
* Participants who are likely to need treatment with IV heparin within 48 hours
* Significant or life-threatening condition
* Women who are pregnant or nursing
* Receiving chronic systemic immunosuppressive therapy such as chemotherapy or prednisone
* CD4 count \<200 cells/mm\^3 in participants with known human immunodeficiency virus or acquired immune deficiency syndrome
* Neutropenia
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02452918
Study Brief:
Protocol Section:
NCT02452918